EFPIA Names Joe Jimenez as New President
EFPIA announced that Joe Jimenez, CEO of Novartis, will be its new president. More... |
| |
Baxter Enters Agreement to Sell Vero Cell Vaccines Platform
Baxter announced that it had entered into an agreement to sell its Vero cell technology and related assets to Nanotherapeutics. More... |
| |
| Industry News |
Taking a Closer Look into the Life-Science Funding Landscape in Europe and the United Kingdom
The author looks at how life-science research has evolved in Europe and the United Kingdom, and discusses the current funding opportunities for SMEs. More... |
| |
Singapore Unveils Workforce Development Plans for Biopharmaceutical Sector
The Singapore Workforce Development Agency collaborated with governmental groups and industry players to develop a plan to supply biologics-manufacturing workforce demand. More... |
| |
Vetter's Expansion of Its Chicago Site Completes Company's Offering in Clinical Syringe Projects
Vetter announced that it added a third cleanroom as part of a US expansion at the Illinois Science and Technology Park in Chicago. More... |
| |
FDA Approves Gardasil 9 for Prevention of Cancers Associated with HPV
FDA announced the approval of Gardasil 9 for the prevention of certain diseases caused by nine types of HPV, five more than the previously FDA-approved Gardasil. More... |
| |
Legal Immunity Offered to Makers of Ebola Vaccines in the US
US Department of Health and Human Services announced a declaration to provide immunity to legal claims made in the US in relation to three investigational Ebola vaccines. More... |
| |
Merck Acquires Cubist Pharmaceuticals
The acquisition will enhance Merck's "superbug" medication portfolio. More... |
